New trial available: Click on any alert below and access our regulatory alerts and get timely notifications sent to your inbox for 7 days.
17th March 2023
9th November 2022
US - Arkansas: Voters rejected a ballot initiative to legalise recreational cannabis, press reports. The initiative would have amended the state constitution to legalise recreational cannabis and allowed for the adult purchase and possession of up to 1 oz of cannabis; it would not have allowed home cultivation.
23rd September 2022
12th August 2022
8th August 2022
US - Arkansas: Responsible Growth Arkansas, organisers of a ballot initiative to legalise recreational cannabis, have filed a lawsuit with the Arkansas Supreme Court after state election commissioners rejected the initiative over a flaw in its title, local media reports. The organisers are requesting an injunction that would allow the initiative to be on the November ballot.
4th August 2022
US - Arkansas: The State Board of Election Commissioners declined to certify a ballot initiative to legalise recreational cannabis because a THC limitation was not covered in the title, press reports. Responsible Growth Arkansas, organisers of the initiative, will reportedly appeal against the decision. The secretary of state’s office said last week that the initiative had gathered enough signatures to advance in the process to reach the November ballot.
1st August 2022
11th July 2022
US - Arkansas: Responsible Growth Arkansas, organisers of a ballot initiative to legalise recreational cannabis, have submitted 190,000 signatures – more than double the number required to reach the November ballot, press reports. The initiative would amend the state constitution to allow up to 40 dispensaries and 12 cultivation licences, and to allow possession of up to 1 oz of flower for recreational purposes. An additional sales tax of 10% would be imposed on sales.
Sign up to access our business and regulatory briefings and get the most updated news, insights and our expert analysis to keep you on top of worldwide industry trends.
By signing up you agree to our Terms and Conditions Please note trial access may take up to 24 hours to be granted as access must be qualified by a member of the CBD-Intel team.